Literature DB >> 30861066

Lack of Toxicity With Long-term Isavuconazole Use in Patients With Hematologic Malignancy.

Adam J DiPippo1, Dimitrios P Kontoyiannis2.   

Abstract

Prolonged courses of isavuconazole (ISA) are increasingly utilized in immunocompromised patients. Toxicities have been reported with long-term use of the other triazoles. We report the first real-life tolerability data in 50 patients with hematologic malignancy receiving ≥6 months of ISA. ISA was well tolerated in our ill patient population.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  hematologic malignancy; invasive mold infections; isavuconazole; toxicity

Mesh：

Substances：

Year:  2019        PMID： 30861066     DOI： 10.1093/cid/ciz159

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  4 in total

1.  Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).

Authors:  Arnau Monforte; Ibai Los-Arcos; Maria Teresa Martín-Gómez; David Campany-Herrero; Judith Sacanell; Cristina Berastegui; Ester Márquez-Algaba; Abiu Sempere; Xavier Nuvials; Maria Deu; Lluís Castells; Francesc Moreso; Carles Bravo; Joan Gavaldà; Oscar Len
Journal:  Microbiol Spectr       Date:  2022-02-16

2.  How to Treat a Child With a Concurrent Diagnosis of Leukemia and Generalized Mucormycosis? Case Report.

Authors:  Patrycja Sosnowska-Sienkiewicz; Kinga Błaszczyk; Honorata Kubisiak-Rzepczyk; Przemysław Mańkowski; Danuta Januszkiewicz-Lewandowska
Journal:  Front Med (Lausanne)       Date:  2022-02-25

3.  Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study.

Authors:  Chiara Cattaneo; Alessandro Busca; Doriana Gramegna; Francesca Farina; Anna Candoni; Monica Piedimonte; Nicola Fracchiolla; Chiara Pagani; Maria Ilaria Del Principe; Maria Chiara Tisi; Massimo Offidani; Rosa Fanci; Stelvio Ballanti; Angelica Spolzino; Marianna Criscuolo; Francesco Marchesi; Gianpaolo Nadali; Mario Delia; Marco Picardi; Margherita Sciumé; Valentina Mancini; Attilio Olivieri; Mario Tumbarello; Giuseppe Rossi; Livio Pagano
Journal:  Hemasphere       Date:  2019-11-04

4.  Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant.

Authors:  Hiba Dagher; Ray Hachem; Anne-Marie Chaftari; Ying Jiang; Shahnoor Ali; Rita Deeba; Shivan Shah; Issam Raad
Journal:  J Fungi (Basel)       Date:  2022-01-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.